Fortrea Holdings (FTRE) Capital Expenditures (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Capital Expenditures came in at $9.0 million in Q2 2026, up 20.0% on a YoY basis from $7.5 million in Q2 2025, and up 12.5% quarter-over-quarter from $8.0 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Capital Expenditures (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Capital Expenditures for 5 consecutive years, with $9.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Capital Expenditures rose 20.0% year-over-year to $9.0 million; the trailing twelve-month figure through Jun 2026 stood at $31.8 million (up 106.49% YoY), and the FY2025 full-year result was $25.2 million, down 1.18% from the prior year.
- Capital Expenditures improved to $9.0 million in Q2 2026 per FTRE's latest filing, from $8.0 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $18.4 million in Q4 2022 and bottomed at -$3.2 million in Q4 2024.
- Historically, Capital Expenditures has averaged $9.0 million across 5 years, with a median of $8.6 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures plunged 134.04% in 2024, then surged 334.38% in 2025.
- Over 5 years, Capital Expenditures stood at $18.4 million in 2022, then sank by 48.91% to $9.4 million in 2023, then slumped by 134.04% to -$3.2 million in 2024, then soared by 334.38% to $7.5 million in 2025, then advanced by 20.0% to $9.0 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $9.0 million, $8.0 million, and $7.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 198.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 23.91 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -42.42 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 31.11 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 9.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 2.62 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 125,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -55,941.69 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Mar 31, 2026 | 8.00 Mn |
| Dec 31, 2025 | 7.50 Mn |
| Sep 30, 2025 | 7.30 Mn |
| Jun 30, 2025 | 7.50 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | -3.20 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 11.20 Mn |
| Mar 31, 2024 | 9.30 Mn |
| Dec 31, 2023 | 9.40 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Jun 30, 2023 | 9.60 Mn |
| Mar 31, 2023 | 16.20 Mn |
| Dec 31, 2022 | 18.40 Mn |
| Sep 30, 2022 | 17.00 Mn |